DrugCard vs Unlearn.AI (2026): Pricing, Features & Which to Choose

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

Lower starting price
Not comparable
Not comparable: DrugCard does not list a price
Free plan
Tie
Neither has one
Higher rating
Tie
4.2 against 4.2
Same job?
Yes
Both are Healthcare AI tools

Side by side

Compared on	DrugCard	Unlearn.AI
Our rating	4.2	4.2
Starts at	Not listed	Not listed
Free plan	No	No
Category	Healthcare AI	Healthcare AI
Plans	See pricing	See pricing
Key features	AI literature screening across 100+ languages Coverage of 1,500+ local and international medical journals Adverse-event signal detection for pharmacovigilance teams Regulatory intelligence and safety database tooling Automated global assessment reporting	Digital twins forecasting participant outcomes Control arm size reduction of around 33 percent Scout for literature and regulatory search Hindsight dataset exploration and SimLab scenario modelling Real-time trial quality monitoring
Pros	Local-language coverage addresses a gap most competitors leave open Founded by someone with direct pharmacovigilance industry experience Operating in 121+ countries with a substantial processed-article volume	Fewer control participants is an ethical gain as well as a commercial one Covers planning, monitoring and analysis rather than one stage Four-plus months of enrolment time saved on their figures
Cons	No published pricing, so budgeting requires a sales conversation Narrow focus on pharmacovigilance limits use outside drug safety Small company relative to larger regulatory-software vendors	No published pricing Digital twin methods need regulatory acceptance per trial context A forecast substituting for an observation is an argument reviewers must accept
Company	DrugCards, founded 2019	Unlearn.ai, Inc.

Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.

FAQ

Questions people ask

Is DrugCard better than Unlearn.AI?

In our reviews DrugCard scores 4.2 and Unlearn.AI scores 4.2. The better pick depends on the job. DrugCard: AI-powered literature-screening platform that automates pharmacovigilance and adverse-event monitoring across languages. Unlearn.AI: Digital twins of trial participants that shrink the control arm by about a third.

Which is cheaper, DrugCard or Unlearn.AI?

DrugCard: see pricing. Unlearn.AI: see pricing.

Do DrugCard and Unlearn.AI have free plans?

Neither lists a free plan.

More comparisons

DrugCard compared with

All DrugCard alternatives

Unlearn.AI compared with

All Unlearn.AI alternatives